SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------
FORM 8-K
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 13, 2003
---------------------
(Date of Report)
REGMA BIO TECHNOLOGIES INC.
-----------------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEVADA 000-30995 N/A
---------------- ---------------- -------------
(State or other jurisdiction (Commission File No.) (IRS Employer ID)
of incorporation)
4861 Cambridge St.
Burnaby, British Columbia
Canada V5C 1H9
-----------------------------------------------------
(Address of principal executive offices and Zip Code)
(604) 622-6209
------------------
(Registrant's telephone number, including area code)
===============================================================
ITEM 4. Change in Registrant's Certifying Accountant
On October 13, 2003, Regma Bio Technologies Limited (the "Company"), notified
BDO Stoy Hayward, Chartered Accountants and Registered Auditors ("BDO"), its
independent public accountant, that the Company was terminating their services,
effective as of that date. The Company's Board of Directors approved such
decision.
The reports of BDO Stoy Hayward on the financial statements of the Registrant
for the past two fiscal years ended December 31, 2002 contained no adverse
opinion or disclaimer of opinion and were not qualified or modified as to audit
scope, or accounting principle but were modified so as to uncertainty related to
the company's ability to continue as a going concern. During the two most recent
fiscal years and the subsequent no disagreements with BDO on any matter of
accounting principles or practices, financial interim period preceding October
13, 2003 (the date of termination), there were statement disclosure, or auditing
scope or procedure, which disagreements, if not resolved to the satisfaction of
BDO, would have caused disagreements in connection with their report on our
financial statements for any such periods.
The Registrant requested BDO Stoy Hayward to furnish a letter addressed to the
Securities and Exchange Commission stating whether or not BDO Stoy Hayward
agrees with the statements made above and, if not, stating the respects in which
it does not agree. A copy of this letter, dated October 17, 2003, is filed as
Exhibit 16.1 to this Form 8-K.
On October 13, 2003, the Company engaged Manning Elliott, Chartered Accountants
("Manning"), as its independent public accountants. The Company did not
previously consult with Manning regarding any matter, including but not limited
to:
o the application of accounting principles to a specified transaction, either
completed or proposed; or the type of audit opinion that might be rendered
on the Company's financial statements; or
o any matter that was either the subject matter of a disagreement (as defined
in Item 304(a)(1)(iv) of Regulation S-B and the related instructions) or a
reportable event (as defined in Item 304(a)(1)(v) of Regulation S-B).
The Company elected to change auditors primarily due to the Company's management
team now operating in North America and, as such, believed it was impractical to
continue to use auditors based in the United Kingdom.
ITEM 7.
Exhibits
16. Letter from BDO Stoy Hayward, Chartered Accountants and Registered Auditors,
dated October 17, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated this 17th day of October, 2003.
REGMA BIO TECHNOLOGIES Limited
BY: /s/ David Rooke
-----------------
Dr. David Rooke, President and
Chief Executive Officer